Acorda Therapeutics, Inc. (ACOR) NASDAQ

Currency In USD

Acorda Therapeutics, Inc.

Address

420 Saw Mill River Road

Ardsley, NY 10502

United States of America (the)

Phone

914 347 4300

Website

https://www.acorda.com

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

102

First IPO Date

February 10, 2006

Key Executives

Name	Title	Pay	Year Born
Ron Cohen	Founder, Chief Executive Officer, President & Director	984,150	1956
Michael A. Gesser	Chief Financial Officer	459,150	1963
Kerry Clem	Chief Commercial Officer	592,225	1970
Felicia Vonella	Vice President of Investor Relations	0	N/A
Sofia Ali	Senior Vice President of Operations & Strategic Planning	0	N/A
Andrew Mayer	Senior Vice President	0	N/A
Denise J. Duca	Executive Vice President of Human Resources	0	N/A
Tierney Saccavino	Executive Vice President of Corporation Communications	0	N/A
Neil S. Belloff	General Counsel & Corporate Secretary	0	1960
Robert Morales	Interim Principal Accounting Officer, Principal Financial Officer, Vice President of Finance & Controller	0	1968

Description

Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.